Asheesh is the Financing columnist for Entrepreneur Magazine and Entrepreneur.com and has written a widely read monthly column for several years. He is the CEO of Virgin Money USA, part of Richard Branson's Virgin Group, and oversees corporate development opportunities in the US financial services market for Virgin. His background includes 15 years of consulting, managing, and investing. Asheesh began his career at the Monitor Group, a strategy consulting and investment advisory firm based in Cambridge, Massachusetts. He subsequently worked with the World Bank in Washington, DC, where he first discovered the enormous demand for financial products that serve the needs of the informal credit marketplace. After leaving the World Bank, Asheesh returned to Monitor as an Entrepreneur-in-Residence and founded CircleLending in 2001, introducing person-to-person lending to the financial services industry and to consumers. In May of 2007, the Virgin Group acquired CircleLending. The company re-launched under the Virgin Money USA brand in October 2007 as the stepping stone to a major Virgin-branded financial services company in the US. In 2008, Asheesh led the acquisition of Lendia, a mortgage processing company with a web-based platform, and integrated the company with Virgin Money USA.
Asheesh is a frequent speaker at industry conferences and commentator on financial innovation in the media. He has been quoted in the Wall Street Journal, New York Times, and Time Magazine, and highlighted in broadcast segments on PBS and NPR. Asheesh is a graduate of the Wharton School at the University of Pennsylvania, and Oxford University, where he received a Commonwealth Scholarship.
Mr. Afonso is Co-Practice Leader of the firm's Boston Government Law & Strategies Group. With 20 years of energy, legislative and regulatory experience and a strong background in international trade law, Mr. Afonso is noted for his expertise in regulatory policies and legislation related to electricity, gas, water, cable television, telecommunications, pipeline engineering and safety, railway, trucking and bus services.
Mr. Afonso served as Chairman of the Massachusetts Department of Telecommunications and Energy (DTE) from 2003 to 2005,and is also the former General Counsel for the Massachusetts DTE, where he acted as chief legal and policy advisor to the chairman and commissioners. In this role, he helped oversee state regulatory policies, governing rates and quality of service for electric generation, gas supply, telecomunications, cable television and transportation.
Dr. Milind Antani, is the Chair of Life Sciences practice in Mumbai, India at the Nishith Desai Associates, a global legal & tax counseling firm and a TiE global sponsor. The Life Sciences practice at his firm focuses on advising clients on the legal regulations in India such as the Drug and Cosmetics Act of 1940, the Environment Protection Act of 1986 and Guidelines issued by the Department of Biotechnology as well as other rules and regulations pertinent to preserving the intellectual property of new products in biotechnology and life sciences. Moreover, for their global clients, his firm also co-ordinates filings with the U.S. Patent and Trademark Office. His firm also negotiates licensing agreements for development and commercialization of technology. With offices in Mumbai, Bangalore, the Silicon Valley, and Singapore, Nishith Desai Associates is a research-focused global organization providing strategic, legal and tax services to entities which are or aspire to be global irrespective of size, sector or nationality.
Jeffrey Andrews joined Atlas Venture in 2001 and is a Partner in the technology group. He invests in hardware and software companies serving large and growing markets such as energy, mobile electronics and media.
Jeffrey currently sits on the boards of Atlas portfolio companies Gotuit, Lilliputian and Pixtronix, and also works closely with Miasole.
Before joining Atlas, Jeffrey made venture capital investments for Intel Capital and spent 10 years in operating roles at Becton Dickinson and Lockheed Martin. He holds six patents, four in fiber optics and two in medical systems. He was twice named Inventor of the Year at Lockheed Martin Aero and Naval Systems, and has authored numerous publications in technical journals.
Jeffrey holds a BS in Physics from Binghamton University, an MS in Electrical Engineering from Virginia Tech and an MBA from Johns Hopkins University.
Greg Arnette is the co-founder and CTO for Sonian, Inc, a two year old cloud compute application start-up that provides enterprise content archiving services for compliance, e-discovery and storage management. Sonian has built it's entire hosted infrastructure on cloud computing environments, and was recently awarded a finalist position in the Amazon Web Services Start Up Challenge. Sonian is an example of new companies building businesses using cloud infrastructure, solving a big problem for a world-wide audience.
Tom Ashbrook is host of National Public Radio's interview show "On Point", produced by WBUR Boston. Tom was raised on an Illinois farm, studied history at Yale, and in India at Andhra University. He worked as a surveyor and dynamiter in the Alaskan oilfields before taking his first job in news as a reporter for the South China Morning Post in Hong Kong. An award-winning journalist in print and broadcast, he served as Tokyo bureau chief, foreign editor and deputy managing editor at the Boston Globe. He spent ten years in Asia, and has reported as a foreign correspondent from hotspots around the world: Beijing, Moscow, Manila, the Balkans, Rwanda, Somalia and more.
In 1995, Ashbrook was awarded a Nieman Fellowship at Harvard University. The following year he co-founded the $70 million Internet start-up HomePortfolio.com, a venture chronicled in his 2000 book The Leap. ("A great adventure tale," says USA Today) In September, 2001, he was enlisted by NPR to host emergency coverage of the 9/11 terrorist attacks. That coverage grew into the award-winning news and interview program, "On Point". "On Point" now airs on more than 150 stations coast-to-coast, including Boston, New York and Washington, and globally on XM and Sirius Satellite Radio. Its top audience ratings have made it the fastest-growing talk show on NPR.
Tom lives in Newton, Massachusetts with his wife Danielle Guichard-Ashbrook, dean of international students at MIT.
Christopher Austin is a partner in the Corporate Department of Ropes & Gray, and is the co-head of the Technology Company and Venture Capital Practice Group, focusing on the representation of public and private technology companies, investment banks and venture capital funds. Christopher is resident in the Boston office, and spent three years in the San Francisco office of Ropes & Gray.
Christopher has represented Goldman Sachs, Merrill Lynch, Morgan Stanley and other investment banks in connection with initial public offerings and follow-on offerings of technology companies, including particularly health care IT companies.
Christopher has been counsel to numerous software, medical device and other technology companies from incorporation through venture funding and final exit, including advising clients regarding mergers and acquisitions, intellectual property issues, IT outsourcing arrangements, joint ventures and other matters. Current technology company clients include Lumera Corporation, G2 Microsystems, Mashery, WirelessInk and other Web 2.0 and software companies.
He has also represented Cutlass Capital, 3i Group PLC and North Bridge Venture Partners on various investments.
Peter Barrett is a Partner in the life sciences group and joined Atlas Venture in 2002.
Previously, he was a co-founder, Executive Vice President and Chief Business Officer of Celera Genomics. Within two years of the founding of the company (1998), Celera announced the first successful sequencing of the human genome. Peter helped launch Celera as a publicly traded entity in 1999. He led Celera's strategic alliances and acquisitions and participated in raising nearly $1 billion in capital for the company.
Prior to Celera, Peter held senior management positions at The Perkin-Elmer Corporation, most recently serving as Vice President, Corporate Planning and Business Development. During his tenure, he expanded the life science business units through a series of licensing agreements, partnerships and acquisitions including: Applied Biosystems and PerSeptive Biosystems. Also during this time, Peter co-founded Celera Genomics with Dr. J. Craig Venter and the Applera Corporation management team.
Peter currently serves on the boards of Atlas portfolio companies Archemix, Aureon Laboratories, Helicos Biosciences (NASDAQ: HLCS), InfaCare Pharmaceuticals, IVREA Pharmaceuticals, Stromedix, Vitae Pharmaceuticals and Zafgen. He is chairman of the board at IVREA and Zafgen and lead Director at Archemix.. Previous Board seats include Atlas Venture portfolio companies Alnylam (NASDAQ: ALNY) and Momenta Pharmaceuticals (NASDAQ: MNTA)
Peter is currently Vice Chairman of the Advisory Council of the Barnett Institute of Chemical and Biological Analysis at Northeastern University, as well as Adjunct Professor at the Barnett Institute. He also serves as President of the Autism Consortium, a non-profit institution.
Peter received his Bachelor of Science in Chemistry from Lowell Technological Institute (now known as the University of Massachusetts, Lowell) and his Ph.D. in Analytical Chemistry from Northeastern University. He also completed Harvard Business School's Management Development Program.
Amar Bhide is the author of The Venturesome Economy: How Innovation Sustains Prosperity in a More Connected World (Princeton University Press 2008) and The Origin and Evolution of New Businesses (Oxford 2000). Bhide has been studying entrepreneurship for about twenty years.
Bhide is a Member of the Center on Capitalism and Society and spearheaded the launch of its eponymous journal, Capitalism and Society (published by the Berkeley Electronic Press) which he now edits (with Prof. Edmund Phelps). He is also a member of the Council on Foreign Relations and a Fellow of the Royal Society of Arts (RSA).
Bhide served on the faculties of Harvard Business School (from 1988 to 2000) and the University of Chicago's Graduate School of Business. A former Senior Engagement Manager at McKinsey & Company and Vice President at E.F. Hutton, Bhide served on the staff of the Brady Commission which investigated the stock market crash. Bhide earned a DBA (1988) and an MBA with high distinction as a Baker Scholar (1979) from Harvard. He received a B.Tech from the Indian Institute of Technology in 1977.
Bhide has several publications in the areas of entrepreneurship, strategy, financial markets and firm governance. His eight Harvard Business Review articles include "Efficient Markets, Deficient Governance," "How entrepreneurs craft strategies that work," "Bootstrap Finance: the Art of Start-ups," and "Hustle as Strategy." His work on financial markets and governance includes "The Hidden Costs of Stock Market Liquidity" in the Journal of Financial Economics and articles in the Journal of Applied Corporate Finance. Other publications include Of Politics and Economic Reality (Basic Books: 1984) and numerous articles in the Wall Street Journal, The New York Times, and The LA Times.
Paul Bleicher, MD PhD, is Chief Medical Officer for Health Insight Technology. Prior to joining the founding team of HIT, Paul Bleicher was the Chairman and founder of Phase Forward which he helped grow over an 11 year period from concept to the leading provider of clinical trial data management software and safety solutions for the biopharmaceutical industry. He was the original CEO of Phase Forward, and operationally managed the marketing, regulatory, and mergers and acquisitions functions at different times during his tenure and remains a member of the Board of Directors. Before Phase Forward, Dr. Bleicher served as Vice President of Clinical Affairs at Alpha-Beta Technology, and Director, Early Phase Services at PAREXEL International. Dr. Bleicher received his MD and PhD from the University of Rochester School of Medicine and Dentistry, specializing in cellular immunology, and his BS from Rensselaer Polytechnic Institute. He trained in internal medicine at the Beth Israel Hospital, and dermatology at Harvard Medical School/ Massachusetts General Hospital; did a post-doctoral fellowship at the Dana Farber Cancer Institute in molecular biology, and began his career as an Assistant Professor at the Massachusetts General Hospital and Harvard Medical School.
As a Managing Director of General Catalyst Partners, Larry invests in both new and existing technology businesses. Areas of special interest include: open source, information technology; systems; and software on-demand business models. Larry is a board member of Advanced Electron Beams; Black Duck Software; Demandware; HubSpot; Optaros; QUMAS and VisibleMeasures, which are all active General Catalyst investments. Larry also served on the Board of Venetica, a General Catalyst investment that was acquired by IBM in October 2004.
Prior to joining General Catalyst, Larry was the chairman, president and CEO of NetGenesis, a market leading software and analytic solutions provider. Larry led NetGenesis from 1997 to 2001, overseeing the company's business, product strategy and direction. During this time, NetGenesis was a two-time Deloitte & Touche Fast 50 award winner and was included among the Inc 500. In February 2000, Larry took the company public (NTGX) and in December 2001, NetGenesis was acquired by SPSS, Inc. (SPSS).
Prior to his role as CEO and president of NetGenesis, Larry was president of PC DOCS, Inc. (DOCSF), a leading developer of document management software for enterprise networks. Under his leadership, PC DOCS' product advanced to the number one market position. He also led the company's public offering in 1998. Prior to joining PC DOCS, Larry was senior vice president of marketing and business development at Interleaf, Inc. (LEAF), where he defined and implemented the corporate strategy that put its electronic publishing solutions in a top market position and helped grow the business to more than $120 million in revenue.
An acknowledged thought leader, Larry has spoken at leading industry events and has been a guest lecturer at Harvard, Stanford, and the Amos Tuck School of Business at Dartmouth. He was also a founder and the first president of OASIS, the industry consortium promoting XML adoption.
Larry is an honors graduate of the University of Massachusetts, Amherst, and holds a masters of arts degree in Linguistics from Clark University.
Janice Brodman has 20+ years of experience designing and managing complex projects in Africa, Asia, and South East Europe, which use information and communications technologies (ICT) to expand access to economic opportunities, healthcare, and participation in political decision-making. Her innovative projects forge strong public-private partnerships. They include: the Excellence in Innovation project in Bosnia-Herzegovina, which uses ICT to strengthen the competitiveness of agribusinesses (from producers to processors), and small/medium enterprises in other key industries; Multimedia for Agriculture project created professional multimedia training programs for Indian agricultural engineers; Multimedia Center of Excellence project in the Philippines created a Multimedia Center that led Philippines health communications efforts; online working group projects drew thousands of members in 100+ countries to examine development issues including women in agriculture. She is the author of seminal works on using ICT in developing countries. Her clients include: USAID, UN agencies, World Bank, other international organizations. She worked with a management consulting firm to Fortune 500 clients to develop their "IT for Strategic Advantage" practice, which led to the firm's profitable sale to Cap Gemini. She taught a course at the Kennedy School of Government on using ICT to improve decision-making, and holds a Ph.D. from Harvard University.
In 1997, Jonathan Bush co-founded athenahealth as a women's health practice management company. Today, through its national network, athenaNet®, athenahealth has emerged as one of the largest and fastest growing providers of on-demand billing, practice management and electronic health record services to medical groups in the United States, but the vision is the same; bring process integrity to the delivery of health care.
Before athenahealth, Bush was an EMT for the City of New Orleans, a combat medic in the U.S Army, and a managed care strategy consultant for Booz-Allen & Hamilton.
He earned a Bachelor of Arts degree with honors from Wesleyan University and a master's degree with distinction in business administration from the Harvard Business School. He is currently a term member of the Council on Foreign Relations, trustee of the Farm School, and father of five children.
With a distinguished 20-year career in building technology companies, Mark's focus is on identifying nascent opportunities in the communications market. Specifically, he focuses on next-generation enterprise technologies, service provider networks, optical networking, emerging new media technologies and wireless communications.
Mark currently supports board-related activities for Cartiza, LogMeIn, M:Metrics, Everypoint and Polatis. He was formerly on the board of Bitfone, acquired by HP (NYSE, Nasdaq: HPQ). A long-time Prism advisor and executive consultant to the firm, Mark officially joined Prism in January 2005. He has held senior positions for leading companies including, IBM/Rolm Systems, MCI, Cisco and Lightstream. Mark was formerly President of Broadband Services for Broadwing, a next-generation networking company, where he was responsible for over $860 million in revenue. He was also with Providence Equity Partners, where he served as an integral part of the due diligence process for evaluating emerging service providers and advanced technologies.
Mark received his B.S. in Business from Merrimack College and graduated with a C.S.S. in Technology and Management from Harvard University.
Bhaskar Chakravorti joined the HBS faculty in July 2008. He is also a Partner of McKinsey & Company, an international management consulting firm, where he is a leader of the Firm's Innovation practice and has served on its Knowledge Services Committee, which oversees McKinsey's 1,200 person global research system. At HBS, he teaches and writes on entrepreneurship management, new venture formation and innovation. Bhaskar has advised CEOs, Boards and senior management of the global leaders in multiple industries (technology, health and consumer care and renewable energy) on innovation, growth and new business-building. In 15 years of consulting he has advised over 30 companies in the Fortune 500. He has helped start new businesses that have scaled up in established companies, re-positioned private equity portfolio companies for growth and has been involved in the public policy arena with regulators and on Capitol Hill. His clients and scope of work cover many geographies in addition to the U.S. and the EU: e.g., Brazil, India, Malaysia, South Korea, Philippines, Canada, multiple African countries. Bhaskar's book, The Slow Pace of Fast Change: Bringing Innovations to Market in a Connected World, Harvard Business School Press; 2003, and over 35 articles are on the topics of innovation, entrepreneurship, strategy, decision-making and mechanism/organization design through applications of game theory.
As a co-founder and Managing Director of .406 Ventures, Maria brings 23 years of entrepreneurial, operating and senior management sales and marketing experience in venture-backed technology companies, with particular strengths in IT security and technology driven services (e.g. managed services, software as a service etc.). Maria focuses on investments in the IT Infrastructure and Security industry. She is actively involved as an investor and board member in Bit9, Digitalsmiths, Kaltura, Memento and Veracode. Prior to founding .406, she was Senior Vice President of VeriSign, following its 2005 $144 million acquisition of Guardent — a Sequoia, CRV and NEA backed IT security company that Maria co-founded and led as Chief Executive Officer and Chairman. Prior to Guardent, she was Senior Vice President for sales and marketing at i-Cube, an IT services company, which was acquired by Razorfish in 1999 for $1.8 billion. From 1993 to 1997, she was responsible for North American sales at Shiva, the category creating remote access company. Maria has received numerous industry awards and honors including "Massachusetts CEO of the Year 2004" and Ernst & Young "Entrepreneur of the Year 2003." Additionally, Maria was named one of the top 25 women in Information Security by Information Security Magazine and inducted by Women's Business Magazine into the "Women's Business Hall of Fame." She holds a BA in English from Mount Holyoke College, where she served as a Trustee from 2003-2008 and where she currently serves on the Investment Committee.
Prior to founding Lionbridge in 1996, Cowan was executive vice president and member of the Management Committee for R.R. Donnelley & Sons. He also was chief executive officer of Stream International Inc., a multi-billion dollar division of R.R Donnelley. Cowan joined R.R. Donnelley in 1988 as senior vice president of the Documentation Services Group, and later became group president.
Prior to Donnelley, Cowan was president and chief executive officer of CSA Press of Hudson, Mass., a 1986 acquisition of R.R. Donnelley. He also held positions at Compugraphic Corporation, in Wilmington, Mass., and London, England.
Cowan is currently a member of the Board of Directors and the Audit Committee of LoJack Corporation (NASDAQ: LOJN). He is also Chairman of the Board of Directors of Sielox LLC and a member of the Board of Directors of Invoke Solutions. Cowan is a member of the Board of Trustees of Deerfield Academy. Cowan served as Chairman of Interleaf until its sale to Broadvision; Chairman of FairMarket until its sale to eBay and Chairman of NewsEdge Corporation until its sale to Thompson. He was also a member of the Board of Directors of Webline until its sale to Cisco. Cowan received his A.B. and M.B.A. from Harvard University.
Nick currently serves as President of the New England Clean Energy Council, a trade group formed in early 2007. The Council's mission is to accelerate New England's clean energy economy to global leadership by building an active community of stakeholders and a world-class cluster of clean energy companies.
Before joining the Council, he was the CEO and founder of Conjoin, a developer of sales productivity software for corporate sales teams. The company was acquired by Intranets.com (subsequently acquired by WebEx).
Previously, Nick co-founded and served as VP Marketing for Wildfire Communications, which brought to market a voice recognition-based electronic assistant for managing all of an individual's telephone activities. Wildfire was acquired by Orange PLC, now a subsidiary of France Telecom.
Nick also served as Vice President of Marketing for C-bridge Internet Solutions, Director of Marketing for PRI Automation, and Product Manager for Apollo Computer.
Nick is a representative of The Climate Project, trained by former Vice President Al Gore to educate audiences about the science underlying global climate change. He serves on the Board of the Carlisle Conservation Foundation and the Mass Audubon Council. He is also the author of Excessive Entanglement, a novel, published in 2008.
Nick holds a BA from Georgetown University.
Nirav Desai is a Managing Director of Sparta Group LLC, a Boston-based family investment office, where he manages a global investment portfolio across asset classes including hedge funds, private equity, direct investments, real assets, and public securities. Prior to Sparta, Nirav was a Principal at Paladin Capital Group, a DC-based private equity group focused on general middle market and late-stage venture investments. His previous experience includes investment banking and the US Navy.
Nirav earned his MBA from The Wharton School and BA from the University Of Michigan, Ann Arbor.
John Dix is Editor in Chief of Network World where he is responsible for setting the strategic direction of the newsweekly and overseeing its Web property, NetworkWorld.com. A 29 year industry veteran, Dix worked for International Data Corp. covering developments in networking and distributed processing, Computerworld as the newsweekly's senior communications editor, then in 1986 was part of the team that launched Network World. Dix has served on the boards of many industry trade shows, including Interop, Comnet, Comdex, PC Expo and SatCon.
Nathan joined Frankel Group in 1997 and opened the Cambridge office in 2001. For more than a decade he has led strategically, financially and scientifically oriented engagements across an incredibly wide range client interests. His expertise includes corporate strategy development, new venture creation, technology assessment, product launch & market planning, portfolio management & systems development, business development advisory, and product / franchise lifecycle planning. These efforts have covered the full therapeutic area spectrum, and his technology platform experience has included stem cells, large and small molecules, drug delivery, medical devices, and biomarkers / diagnostics. Clients have included executive teams at global life science firms, emerging mid-size specialists, banks, hedge funds, and start ups.
Before joining FG, Nathan was a senior consultant with Ernst & Young LLP where his engagement experience included mergers & acquisitions, new business creation, operational assessment, & systems integration and support for payer and provider groups. Prior to that Nathan worked at Searle Pharmaceuticals in their Managed Care Strategy group, and was an analyst at CIGNA Healthcare.
Nathan holds an MBA from The University of Chicago, and a B.S. from the University of Connecticut
As a Managing Director at Bain Capital Ventures, Jeffrey Glass focuses on wireless, digital media and consumer marketing technologies. He serves as a board member for a number of companies including Blip.tv, LinkedIn, TargetSpot, BzzAgent, the Massachusetts Innovation Technology Exchange, and the Mobile Marketing Association.
Prior to joining Bain Capital, Jeff was President & CEO of m-Qube, Inc., a Bain Capital Ventures portfolio company recently acquired by VeriSign Inc. He led the company from start-up to becoming the leader in the North American marketplace for the management, delivery and billing of mobile content and applications. The company was named in 2005 by the Boston Business Journal as the fasted growing business in New England. In 2006, Jeff was voted Ernst & Young Entrepreneur of the Year in New England and was also named to the Boston Business Journal's "40 under 40" list.
Jeff also held positions as Founder and President of Transactive Solutions, Chief Operating Officer of Travelers/NETPlus and strategy consultant with the Boston Consulting Group where he focused on multimedia and convergence technologies. Jeff received an M.B.A., with first year honors, from Harvard Business School and a B.A. in Economics and Political Science from Amherst College.
Mike Grandinetti has a unique cross-disciplinary background. He has deep operating experience as a serial venture capital — backed entrepreneur, was involved as an early team member in the launch of several successful new businesses within Hewlett-Packard, and holds long-standing faculty appointments at MIT's Sloan School of Management and the Technical University of Denmark. He has been active in regional and national innovation policy, with a distinct focus on global entrepreneurial coaching and enablement, venture financing and advanced technology commercialization and tech transfer for high potential ventures in the US, Canada, and Europe. He served as a management consultant with McKinsey early in his career.
As a serial entrepreneur and senior operating executive, he has helped lead four venture-backed companies to successful high multiple exits for his investors. He co-led an IPO while with Raptor Systems, raising $70M in capital, and has been actively involved in many successful rounds of institutional venture financing across multiple ventures. He serves as Senior Advisor to a number of global start-ups and VC firms. He is a veteran Judge of the MIT $100K Entrepreneurship Competition and serves as a Judge in the MIT Global Sales Competition. He is a frequent international keynote speaker and panel moderator on themes including entrepreneurship, global Go-to-Market, Sales 2.0, use of social media in B2B, raising venture capital and open innovation.
He received his MBA from Yale, where he was named the annual Jess Morrow Johns Memorial Scholar and was the recipient of the Procter and Gamble Marketing Leadership Award and a Yale Teaching Fellowship. He received his BS in Engineering, magna cum laude, from Rutgers, where he was elected to the National Engineering Honor Society.
Jamie is a mobile entertainment and technology veteran, with a proven track record delivering innovative consumer software products, services and social communities using cutting-edge mobile technologies. As co-founder of MocoSpace, he leads the company's product development and technology initiatives.
Previously he was co-founder of JSmart Technologies, an early pioneer in the mobile games & entertainment industry, where he led the development of an extensive portfolio of casual games and entertainment products across a wide range of mobile technologies. He oversaw JSmart's sale in 2004 to the SK Group.
Jamie holds an MBA from Tel Aviv University.
Paul is the Project Leader for Operation Village Health. Initiated in 2001, this program has used a simple email-based telemedicine platform to extend the reach of Harvard-affiliated specialists to clinicians and their patients in two remote villages of Cambodia. To date, over 1500 patient visits have been enabled. In 2006, Operation Village Health won the Stockholm Challenge Award for innovative use of communications technology in the developing world, taking the top prize among a field of 98 projects from over 50 countries. This project works in partnership with American Assistance for Cambodia.
Operation Village Health is an initiative of the Center for Connected Health, Partners HealthCare, where Dr Heinzelmann completed a fellowship in Telemedicine. A graduate of the University of Wisconsin School of Medicine, he also received a Diploma in Tropical Medicine and Hygiene from the Royal College of Physicians-London and a Master of Public Health degree from the Harvard School of Public Health. He is currently an Instructor in Medicine at the Harvard Medical School and a Primary Care Physician at Massachusetts General Medical Group.
Satish Jindal was a founder and CEO of NeoGenesis Pharmaceuticals which was acquired by Schering-Plough in 2005. Satish stayed on as a Site Head and Vice president at the newly created Schering-Plough Plough research Institute in Cambridge, MA until May 2008 and since then has worked as an interim Global Head Business Development at UCB Pharma and as a Venture Adviosr to new venture firm, Orion. Satish has a postdoctoral experience at Whitehead Institute at MIT, Cambridge.
Since 1983, Chairman of Development Alternatives, a social enterprise headquartered in New Delhi, dedicated to global, national and local sustainable development through innovation of technologies, institutions and policies. TARAHAAT is one of its subsidiaries whose vision is to empower people to achieve their aspirations by using Information and Communication Technology (ICT). TARA Akshar, a product from TARAHAAT has made 54,000 women literate in two years.
Earlier, set up and headed the Office of Environmental Planning and Coordination, Govt of India — the first national environmental agency in the South. Subsequently was Director, INFOTERRA, the global information system of the UN Environment Programme.
Was Special Advisor to the Brundtland Commission. Served as advisor to the United Nations, World Bank, GEF and other inter-governmental and government agencies.
Currently President of the Club of Rome and also President of IUCN. Has served on several international boards, including the Worldwide Fund for Nature (WWF), EXPO 2000 in Hannover, IISD, SEI, ANH; also WEF NGO Council and the World Future Council.
Officer of the Order of the British Empire (OBE). Won the United Nations Sasakawa Environment Prize 2002, the premier global prize in the field. Also received the Klaus Schwab Outstanding Social Entrepreneur Award, Stockholm Challenge Award, and the Nehru Award for Popularising Science.
Ashok Khosla graduated from Cambridge University and received his doctorate in experimental physics from Harvard University. He lectured at Harvard on physics, astronomy and environment. Has also taught at Yale, MIT, Oxford, Turin, Leiden, JNU, and IITs. He has authored more than 300 papers and articles.
After graduating from Boston University, Steve Kropper began his career as "Energy Czar" at Boston City Hospital. After super-insulating his triple-decker home, worldwide oil prices tumbled to $11/barrel, and he decamped to Cornell University to earn his MBA. Next was Cable & Wireless, Bell Canada, Clear Comm. (NZ) and Martin-Marietta. Steve's research at International Data Corp. (IDC) spurred untenably high investment flows into telecom, and singlehandedly drove prices to commodity levels. Pursued by an angry mob, Steve hid in exile in the dotcom real estate and mortgage sector. He founded Domania.com (acquired by Lending Tree) the largest US property dataset which gave consumers access to home prices via AOL, Bloomberg, Dow Jones, Yahoo, Chase, Citi, etc. He briefly helped export America's most promising jobs to India while SVP at Equinox (acquired by iFlex). He next advised Virgin Money, New Homes Realty and many other firms that there would be no bubble in real estate.
Founding Fellow, NE Clean Energy Council; Pickens Plan rep., 7th Congressional District. CEO/founder of WindPole Ventures, a wind power and information firm repurposing ATT's network of 1,150 microwave tower sites.
Steve grew up in Scotland, Ireland and on airplanes. Elected Lexington Town Meeting member and Chair of the Energy Conservation Committee.
Dr. Lampe-Onnerud is a well-known authority in the battery industry. She has pioneered the use of lithium-ion and other materials to deliver more powerful, longer lasting, safer and cost-effective batteries for laptops, PDAs, cell phones and other electronic devices. Prior to founding Boston-Power, Dr. Lampe-Onnerud was one of the youngest partners ever appointed at Arthur D. Little/TIAX, where she ran the company's globally- renowned battery labs, defined strategies for the world's top chemical and battery organizations, and directed high-profile market evaluations. Earlier in her career, she served as a director and senior scientist at Bell Communications Research. Awarded 15 patents in portable power solutions, with 6 patents pending, Dr. Lampe-Onnerud has received a range of industry awards. These include 100 Top Young Innovators by Technology Review, MIT's Magazine of Innovation; a Stevie Award for Women in Business as Best Entrepreneur; finalist in Ernst & Young's Entrepreneur of the Year; Mass High Tech Women to Watch; and Top Innovators of 2008 by EDN Magazine. Dr. Lampe-Onnerud is a frequently sought-after speaker who passionately and eloquently shares her insights about battery technology, climate change and environmental sustainability at industry and government events around the world. Dr. Lampe-Onnerud earned a Ph.D. in Inorganic Chemistry and a B.Sc. in Chemistry and Calculus from Uppsala University in Sweden.
Dr. Lazarus is CEO of Lilliputian Systems, a venture funded developer of micro fuel cells for portable electronics. Lilliputian has developed and markets a revolutionary silicon-based "Fuel Cell on a Chip" for powering portable consumer electronics. At Lilliputian, Dr. Lazarus has raised over $90M from premier venture capital firms, including Kleiner Perkins, Atlas Venture, Rockport Capital, Fairhaven Capital, Altira Group and Stata Ventures.
Prior to Lilliputian Systems, Dr. Lazarus was part of Cymer, Inc.'s (NASD: CYMI) senior management team, holding positions of Senior Vice President, General Manager, ACX Division and Senior Vice President, Software Products and Control Systems. While at Cymer, Dr. Lazarus successfully integrated newly acquired ACX into Cymer and successfully led a major product development program for the company's flagship product.
Prior to Cymer, Dr. Lazarus founded and led Active Control eXperts (ACX), Inc. from inception to successful acquisition by Cymer. During Dr. Lazarus' tenure, the company produced over a dozen cutting edge vibration and motion control products in the sporting goods, industrial, automotive and semiconductor industries. ACX grew at over 50% CAGR, ranked #79 on the Inc. 500 list of America's fastest growing private companies and earned numerous awards including Popular Science's "Best of What's New" award.
Dr. Lazarus also serves on the Board or Advisory Board of several start-up companies including Dataxu, a Web 2.0 company, VehicleSense, a wireless networking company and Celery, a developer of email to fax networking software. Recently, Dr. Lazarus was recognized as a Technology Pioneer by the World Economic Forum.
Dr. Lazarus holds a Masters and Ph.D. in Aeronautics and Astronautics from MIT and a Bachelor of Science and Engineering from Duke University. Dr. Lazarus is the author of numerous journal articles and holds over 20 patents.
Thomas H. Lee, MD, is an internist and cardiologist, and is Network President for Partners Healthcare System, the integrated delivery system founded by Brigham and Women's Hospital and Massachusetts General Hospital, and Chief Executive Officer for Partners Community HealthCare. He is a graduate of Harvard College, Cornell University Medical College, and Harvard School of Public Health. He is a Professor of Medicine at Harvard Medical School and Professor of Health Policy and Management at the Harvard School of Public Health. His research interests include risk stratification and optimal management strategies for common cardiovascular problems, and improvement of quality of care, with a particular focus on critical pathways, guideline development and implementation, and managed care.
Dr. Lee is co-chair of the Committee for Performance Measures of the National Committee for Quality Assurance (NCQA), and has been the Chairman of NCQA's Cardiovascular Measurement Advisory Panel since 1996. He is a member of the Massachusetts Health Care Quality and Cost Council. He is a member of the Boards of Directors of Geisinger Health System and of Bridges to Excellence. He is a member of the Board on Health Care Services of the Institute of Medicine, and a member of the Board of Overseers of the Malcolm Baldrige National Quality Award. He is the Editor-in-Chief for The Harvard Heart Letter and Associate Editor of The New England Journal of Medicine.
Grew up in northern Maine, where he spent his high school fall vacation breaks working on potato farms. After college, he managed projects at the Portland Public Market, an indoor food market designed to showcase local agriculture. He later ran the capital raising department for the worker-owned cooperative Equal Exchange, a pioneer in fair trade coffee. Most recently, Dwayne worked in environmental finance for Man-ECO, part of Man Investments, the world's largest publicly listed hedge fund manager. Dwayne has a BA from Middlebury College and an MBA from Oxford University, where he was chair of the business school's venture fund.
Cyrus Mehta studied engineering at the Indian Institute of Technology, Bombay and obtained his Ph.D. from MIT in 1973. He is a co-founder and President of Cytel Software Corporation, a leading provider of software and consulting services to the biopharmaceutical industry in the area of adaptive clinical trials. Dr. Mehta is Adjunct Professor of Biostatistics, Harvard University. He publishes extensively in statistics journals and has led the development of several statistical software packages that are widely used in the biopharmaceutical industry. He consults with the biopharmaceutical industry on group sequential and adaptive design, offers workshops on these topics, and sits on several data monitoring committees for these types of clinical trials. In 1987 Dr. Mehta was a co-winner of the George W. Snedecor Award from the American Statistical Association. He was elected a Fellow of the American Statistical Association in 1995 and named the Mosteller Statistician of the Year by the Massachusetts Chapter of the American Statistical Association in 2000. In 2002, Dr. Mehta was named Outstanding Zarathushti Entrepreneur by the World Zarathushti Chamber of Commerce.
William Mitchell is Vice President of Sales and Marketing at Nuvera. He is also the Global Market Leader and sponsor of the firm's automotive product platform and shares responsibilities for managing OEM/partner relationships for automotive customers in the Americas, Europe, and Asia. His primary responsibilities include business development, strategic planning, product strategy, market research, and marketing communications. Prior to taking on his role in marketing, William was Vice President of Engineering and Operations. He has been involved in advanced power systems, combustion, alternative fuels, fuel cells, catalyst technology, and environmental engineering since 1990.
Previously, William was a co-founder and Vice President of Epyx Corporation where he helped launch this technology-intensive start-up company. Before that, he was employed at Arthur D. Little, Inc., as an Engineer and Program Manager of its Hydrogen Technologies Group. William has also been a faculty member at the Pennsylvania State University.
William received BS and MS degrees in Mechanical Engineering from the Pennsylvania State University. He is licensed as a Professional Engineer in Environmental Engineering, and his professional affiliations include the Society of Automotive Engineers, and the U.S. Fuel Cell Council.
Award-winning businessman Dr. Shan Nair is a highly sought after speaker on globalization, a contributing author for various publications and considered an expert in international expansion.
Since first founding Nair & Co. in 1994, Dr. Nair now leads the strategic operations and global group expansion for the company and is driving the company's strong focus on using IT to leverage business advantage. Today, Nair & Co., which is headquartered in the United Kingdom has offices in India, China, the United States and Japan and currently acts for 700+ foreign operations in over 40 countries. With the company at more than 350 employees globally, Dr. Nair's success is evident in that nearly 75% of executives at the company have been seven years or longer at Nair & Co., excluding the most recent recruitment initiative. Also, under Dr. Nair's guidance, Nair & Co. has been named as Top 100 Outsourcing Service Provider in the World by the International Association of Outsourcing Professionals (IAOP).
Dr. Nair is an Oxford University Ph.D. nuclear physicist and was instrumental in developing a code which set the U.K. standard for calculating waste arising from spent nuclear fuel. When the Chernobyl accident occurred, he was one of the two U.K. technical experts selected to assist the European Commission in its post-accident response.
Dr. Nair has received recognition for his success in business including the 2008 Outstanding 50 Asian Americans in Business Award, Asian American Business Development Center (AABDC), New York, NY. U.S.A; 2008 Bharat Samman Pravasi Award, NRI Institute, Delhi, India; 2008 Gulland's Excellence Award, NRI Institute, London, England; and 2009 Hind Rattan (Jewel of India) Award, NRI Welfare Society, Delhi, India.
Dr. Nair has lived in 13 countries in South East Asia, Europe and the Middle East and has over 20 years of work experience. He is a long-standing Charter Member of TiE-Boston, the newly elected President of the Non-Resident Indian Institute, a trustee of Canterbury School in Fort Myers, Florida and a regular contributor to charitable causes in India.
Dr. Dinesh Patel M.D. is Chief of Arthroscopic Surgery at Mass. Gen. Hospital and Associate Clinical Professor of Orthopedic surgery at Harvard medical school. Dr. Patel has been honored by numerous professional,social, cultural organizations here and abroad. He has taught and trained Arthroscopic Surgery all over the world and has been recognized and honored by professional organizations here and abroad. In the February 2002 his peers voted him as one of the "Top Docs" in the field of Orthopedic Surgery (Boston magazine) and has been in US NEWS as well. He was Chairman of Board of Registration in Medicine in Massachusetts and served as a Director on the Federation of State Medical Boards. In April 2003 he was given leadership award by the FSMB. He was chairman of board for licensure of Dubai health care city for three years.
In 2001, he established in Ahmedabad Asia's first Psychomotor lab as non profit, public -private, academic partnership to teach and train doctors and students in Arthroscopic surgery in India. Established A leg to stand on www.altso.org for providing artificial limbs to children's globally and member of Shradha foundation (fcra approved) in India. He has been on global advisory board of Americares a global non profit helping in disasters. www.americares.org. He was Commissioner at Catastrophic Illness for Children's Relief Fund in Massachusetts. In 2006 he was appointed as member of the leadership forum of Harvard school of public health.
One of the founding charter members, director, secretary, in charge of web page, publicity and founder of Life sciences section. Founded idea to execution --ACUFEX which was one of the first in the globe for making innovative designs of instruments for Arthoscopic/ endoscopic surgery and that has sustained even now.
PJ Piper is the Founder, President and Chief Executive Officer of QM Power. QM Power is commercializing a proprietary and patented magnetic circuit for the $70 billion electric motor, generator and actuator markets which provides both the highest efficiency and highest power density (lowest cost, weight and volume) in the same product offerings. QM Power is delivering enabling solutions for the industrial motor, power generation, electric vehicle, linear motion and military markets.
Mr. Piper joined the Company from Aspen Aerogels, Inc., a company he co-founded and spent six years at as Chief Financial Officer. At Aspen Aerogels he raised over $100 million in equity and debt capital, secured multiple manufacturing facilities with a production capacity in excess of $100 million in revenue and successfully commercialized the aerogel nanotechnology in the oil and gas, industrial, automotive, apparel and military markets.
Before joining Aspen, Mr. Piper spent almost ten years in investment banking, commercial lending, mergers and acquisitions and derivatives marketing and management serving the Oil and Gas, Power, Project Finance, Diversified Manufacturing and Middle Market companies at JP Morgan Chase and as an Executive Director at CIBC World Markets. He is a member of the Financial Executives Institute and is a former Board member of Triton Systems, Inc and Founder and CFO of Aspen Products Group.
Christopher Poirier is the Chief Executive Officer of CoalTek, Inc. CoalTek has commercialized a proprietary, pre-combustion clean coal technology platform that provides fuel-based plant efficiency and environmental compliance solutions for coal-fired power generation companies and steel manufacturers. Since joining CoalTek in 2003, Mr. Poirier has spearheaded CoalTek's successful efforts to commercialize and deploy the company's Clean Coal technology, overseeing corporate strategy, operations, financial management, business development and government relations. Prior to his current role at CoalTek, Mr. Poirier founded or led several venture-backed technology companies, including Resinate Corporation, GetPlastic, and JR Medical Technology.
Mr. Poirier has been appointed to the National Coal Council, a special advisory panel to the US Secretary of Energy. Mr. Poirier is also a member of the Newsweek Magazine Global Environmental Advisory Board. He is a member of the board of directors or board of advisors to a number of clean technology/alternative energy companies, including FloDesign Wind Turbine Corporation and OutSmart Power Systems (smart grid). Mr. Poirier acts as a strategic advisor to top venture capital firms investing in the alternative energy and clean tech space. He is also a member of the American Coal Council, a member of the Environmental Committee of the Council of Industrial Boiler Operators (CIBO), and a member of the New England Clean Energy Council's CEO Council. Mr. Poirier has been a guest lecturer at MIT Sloan School of Management and Columbia University Business School.
Mr. Poirier earned his bachelor's degree in marketing and finance from Boston College.
Pam Randhawa draws from over 14 years of experience in the healthcare and life sciences industries. Having worked in product management, consulting, sales, and marketing, her specialized knowledge of market analysis, strategic planning, business development and product management enables her to successfully guide new product evolution and strategic development at Sermo. In her current role as Vice President of Strategic Development, Ms. Randhawa is responsible for identifying and developing new markets in the area of clinical development and post market segments. In addition, Ms. Randhawa will be focusing on the expansion of Sermo solutions to international markets. Prior to joining Sermo, Ms. Randhawa served as Vice President of Marketing at Phase Forward, where she was responsible for the planning and execution of the company's global marketing strategy, including key partnerships, product marketing, market research, marketing communications and programs, sales support, industry analyst relations, and public relations. During her tenure, Ms. Randhawa contributed to the company's market cap growth from just over $225 million in 2005 to over $900 million in 2007, with sales growth over 50 percent, year over year.
Before joining Phase Forward, Ms. Randhawa served as Director of Product Development at InfoMedics, where she expanded opportunities for drug safety and risk management solutions in the pharma marketplace. Prior to InfoMedics, she held several senior roles with McKesson Corporation including, Director of Analytical Development where she effectively used healthcare data to drive business decisions. In this position, Ms. Randhawa leveraged healthcare longitudinal data to advise managed care companies in assessing the effectiveness of various therapies, reducing healthcare costs, and ensuring the quality of care provided to healthcare plan members. Prior to McKesson, she consulted for the MEDSTAT Group on access, costs and quality of care provided to the State of Mississippi's Medicaid population. She also served as an independent consultant to the State of Ohio, Department of Health, where she made recommendations on public health, managed care and long-term care policies and initiatives.
Ms. Randhawa holds a Bachelors Degree in economics from the University of Rajasthan, India, and a Masters Degree in public management from Carnegie Mellon University.
Jorg Riesmeier PhD is responsible for LSP's US office in Boston/Cambridge, MA. Jorg serves on the supervisory boards of Efficas (Boulder, CO), Pasteuria Bioscience (Alachua, FL), Innovative Biosensors (Rockvielle, MD), Asoyia (Iowa City, IA) and Attune (San Francisco, CA). Before joining LSP as a partner in 2006, he worked at Burrill & Company in San Francisco. There, he was seconded from Bayer with responsibility for managing Burrill's AgBio and Nutraceutical funds. Before working with Burrill & Company, Jorg was at Bayer CropScience, where he played a leading role in R&D, business development and strategy focusing on the identification and implementation of New Businesses.
In the mid 1990s, Jorg co-founded and was CEO and President of PlantTec Biotechnology, Germany, which he sold to Aventis CropScience in 2000. As a scientist with the Max-Planck-Institute in Golm, Germany and the IGF Institut für Genbiologische Forschung in Berlin, Germany, Jorg focused on molecular plant biology and physiology. A German native, Jorg has a PhD and a Masters degree in biochemistry from the Free University in Berlin. He has authored numerous articles in leading scientific publications, including EMBO and PNAS.
Mr. Rhoades joined Satcon in May 2008, as President and Chief Executive Officer with more than 20 years of experience in executive leadership positions across the renewable energy arena. With a history of successful experience and business acumen, combined with a deep technical understanding, Mr. Rhoades is widely noted for bringing both leadership perspective and operational excellence to Satcon, as well as the wider renewable energy space.
As President and CEO, Mr. Rhoades is credited with revitalizing Satcon's business and leadership position, by focusing on the company's core key strengths and introducing new products and solutions that will continue to significantly shape the landscape of the solar power environment and support the world's increasing dependence on renewable energy. This approach has led to Satcon's significant gain of market share and increase in revenues. As leader of the Satcon team, Mr. Rhoades is on the forefront of solving some of the most pressing and complex challenges in the renewable energy arena. He was one of the first in the industry to identify PV inverters as a product that offered significant growth potential well beyond the through-put of energy, and led the creation of a power conversion system that significantly improves the way energy is harnessed, managed, controlled and delivered.
Educated at the university of Wales, Oxford and Cambridge, UK, postdoctoral training at Cambridge University UK Weizmann Institute, Israel, MIT, USA. Academic positions at Brandies University MA and Harvard Medical School MA. Academic focus molecular biology of viruses and parasites as regards gene identification and molecular basis of pathogenesis. Career long interest and involvement in global health with a specific focus on facilitating new approaches to infectious decease prevention and control in the developing world. This involvement was started in 1990 by participating in the Children's Vaccine Initiative and continues to the present with involvement in infectious disease control in China.
Founded and established four biotechnology companies between 1982 to the present. Three companies were in the therapeutic area focused on the control and prevention of infectious diseases and the most recent company Stemgent is a stem cell reagent and service company. The speaker is responsible for new technology evaluation and their incorporation into novel stem cell reagents and services. Stem cell biology is fostering new approaches to the process of drug development and their toxicological evaluation. Moreover approaches utilizing stem cells and specific small molecule drugs that regulate their fate could lead to curative therapies for chronic diseases and neurologic injuries.
Jhonatan Rotberg is the founder and the director of the Next Billion Network program at MIT, and the instructor of MIT's NextLab course series. He is the Telmex Researcher at the MIT Media Lab and a Lecturer in the Media Arts and Sciences Program. A serial entrepreneur, he is experienced in the original conception and deployment of innovation, applications and content in developing countries, and in building projects and organizations based on digital technologies. During his career, he has founded and sold various startups in the financial and high-tech sectors.
His current focus is on designing innovative mobile technologies that help people reduce friction in their local markets from the bottom up, and on launching ventures that allow them to scale and become sustainable in emerging markets. Previous to joining Grupo Carso, Latin America's largest telecoms provider, he spent 7 years in the financial services practice of Accenture, and in the Investment Banking divisions of Baring Securities and Deutsche Bank. A native of Mexico, Rotberg is a graduate of Brown University.
Wade Roush is Chief Correspondent for Xconomy. He is a veteran science and technology writer whose recent work has focused on consumer Internet technology, including search, social computing, geocomputing, Web services, online virtual worlds, and the visual Web.
As a staff member at MIT's Technology Review from 2001 to 2006, Wade served as senior editor, San Francisco bureau chief, and executive editor of TechnologyReview.com, and helped lead the magazine to a nomination as National Magazine Award finalist in 2006. Before joining TR, he was the Boston bureau reporter for Science, managing editor of supercomputing publications at NASA Ames Research Center, and Web editor at e-book pioneer NuvoMedia.
Wade graduated Magna cum Laude in the history of science from Harvard College in 1989 and earned a PhD in the history and social study of science and technology from MIT in 1994. His work has appeared in Science, Technology Review, IEEE Spectrum, Encyclopaedia Brittanica, Technology and Culture, Alaska Airlines Magazine, and World Business, and he has been a guest of CNN, CNBC, NECN, WGBH and NPR.
Vinod Sahney, PhD is Senior Vice President and Chief Strategy Officer of Blue Cross Blue Shield of Massachusetts. Dr. Sahney is also a founding member and serves on the Board of Directors of the Institute of Health Care Improvement (IHI) based in Cambridge, MA. IHI works to improve patient care through a variety of strategies. He has spoken extensively on health care quality with a particular emphasis on how health care delivery can be improved significantly by focusing on systems of care and on improving reliability. Dr. Sahney is an elected member of both the Institute of Medicine and the National Academy of Engineering and has been a Visiting Professor of Health Policy and Management at Harvard University for the past 32 years.
Aaron Sandoski is the Managing Director of Norwich Ventures, an early-stage venture capital firm specializing in medtech. He is involved in all facets of the investment process and draws from a broad background in healthcare and start-up operations to support portfolio companies. Prior to founding Norwich Ventures, Aaron worked for DEKA, the engineering think tank of Dean Kamen, where he helped develop partnerships and formulate business plans for emerging technologies. Aaron has also worked in start-up operations where he helped launch a subsidiary of Express Scripts and helped launch a venture-backed payments company. Both companies were acquired in transactions totaling over $500 million. He began his career as a consultant at McKinsey & Company, where he advised healthcare clients ranging from leading medical device companies to a rural hospital system.
Aaron serves as a board member of MedTech IGNITE, an initiative of the Massachusetts Medical Device Industry Council (MassMEDIC) for nurturing early-stage medical device entrepreneurs. He is also co-author of How the Wise Decide, a book on decision-making in business (Crown Business, 2008).
Aaron earned an MBA from Harvard Business School and graduated summa cum laude from Dartmouth College with a double A.B. in Chemistry and Economics.
With over 10 years of experience in the mobile industry, Ganesh Sivaraman now heads Forum Nokia Americas Business Development for Internet Partnerships. Prior to joining Forum Nokia, Ganesh headed the global marketing of Web Technologies & Applications for S60. He transformed Nokia & S60 to be a world leader in enabling Internet technologies on mobile. In over eight years with Nokia, Ganesh held key roles — Global Product Manager, Technology Consultant, Nokia's lead delegate in mobile standardization bodies (Co-Chairman in SyncML, Vice-Chairman in OMA).
He is a recognized speaker in the mobile industry, holds 2 patents, and has a Master's degree in Electronics.
Al is a partner, a co-chair of the firm's Cross Border Practice Group and a member of various firm practice groups. He represents life sciences and IT businesses and investors in venture capital and private equity, corporate work, mergers/acquisitions, collaborations, spin-offs, strategic alliances, licenses, and management compensation issues. Most of his work involves cross-border situations. Al works hard to understand his clients' markets and business objectives.
Al has been recognized in the last three editions of the Practical Law Counsel's Global Counsel 3000 as a "Recommended practitioner in Boston" in two categories: M&A and Company/Corporate Transactions. Al was recently named a Securities & Venture Finance "Super Lawyer" by Law & Politics and Boston Magazine. This designation is based upon the results of a survey of 37,000 Massachusetts attorneys, reportedly to select the top five percent of lawyers in the state.
After Yale, Al moved to Lusaka, Zambia, for three years of micro-credit activities in Africa, primarily as the number two executive of the National Credit Union Association of Zambia. He also took post-graduate courses at the University of Ghana, Africa, and the University of Poitiers, France.
Al led a group of corporate executives in a visit to 15-20 large factories in the former Soviet Union in late 1991, traveling down the Volga River via riverboat. Al is an enthusiastic sea kayaker (he owns four sea kayaks) and cross-country skier. He also is a member of the Apollo Club, the oldest (mid-1800s) men's singing group in the U.S. He is married to a Dane and has two sons.
Dr. Richard Mark Soley is Chairman and Chief Executive Officer of the Object Management Group, Inc. (OMG®) and Executive Director of the SOA Consortium.
As Chairman and CEO of the OMG, Dr. Soley is responsible for the vision and direction of the world's largest consortium of its type. Dr. Soley joined the nascent OMG as Technical Director in 1989, leading the development of OMG's world-leading standardization process and the original CORBA® specification. In 1996, he led the effort to move into vertical market standards (starting with healthcare, finance, telecommunications and manufacturing) and modeling, leading first to the Unified Modeling Language (UML®) and later the Model Driven Architecture (MDA®). He also led the effort to establish the SOA Consortium in January 2007.
Previously, Dr. Soley was a cofounder and former Chairman/CEO of A. I. Architects, Inc., maker of the 386 HummingBoard and other PC and workstation hardware and software. Prior to that, he consulted for various technology companies and venture firms on matters pertaining to software investment opportunities. Dr. Soley has also consulted for IBM, Motorola, PictureTel, Texas Instruments, Gold Hill Computer and others. He began his professional life at Honeywell Computer Systems working on the Multics operating system.
A native of Baltimore, Maryland, U.S.A., Dr. Soley holds the bachelor's, master's and doctoral degrees in Computer Science and Engineering from the Massachusetts Institute of Technology.
Vivek is Managing Partner at Boston Cleantech Partners which works with investors and management teams to build successful cleantech businesses in US and in India. He is a Venture Advisor to a global, expansion-stage, cleantech venture capital fund based in London. Vivek is also an Advisor to the A.T.E. Group, an Indian industrial group. He is helping A.T.E. build and grow cleantech businesses and is on the Boards of some of their cleantech companies. He has served as President, Corporate Technology Strategy and Services at the Aditya Birla Group, one of the largest industrial groups in India. He has also worked at Polaroid Corporation and at Shell Development Company, a Royal Dutch/ Shell Group Company. He received his Ph.D. from the University of Massachusetts, Amherst and his B.Tech. from the Indian Institute of Technology, New Delhi, India. Vivek is a Charter Member of TiE-Boston.
Carl Stjernfeldt has an investment focus on wired and wireless communications technologies and services, on advanced mobility solutions that provide secure high quality access to content and applications, and on next generation video delivery capabilities. Prior to Castile, Mr. Stjernfeldt was a partner at Battery Ventures where he spent seven years investing in leading IT companies. He currently serves or participates on the boards of Agito Networks, Funambol, and PermissionTV. He has served on the boards of Arbor Networks, Broadbus Technologies (acquired by Motorola), Cedar Point Communications, and Tejas Networks, and was a board observer of Optium (NASDAQ: OPTM, acquired by Finisar).
Prior to Battery Ventures, Mr. Stjernfeldt was a client partner and project manager for Cambridge Technology Partners, delivering large mission-critical system implementations for Fortune 100 clients. Mr. Stjernfeldt started his career as an engineer at Summa Four, developing telecommunications solutions for domestic and international service providers, later rising to engineering management before starting an application development department.
Mr. Stjernfeldt holds a dual MS in Electrical Engineering from the Royal Institute of Technology (KTH) in Stockholm and Northeastern University in Boston, and an MBA from the Massachusetts Institute of Technology's Sloan School of Management where he now teaches a course in entrepreneurial finance.
Mr. Stjernfeldt is active at MIT serving as a Catalyst for the Deshpande Center, judging MIT's 100K competition, and teaching an entrepreneurial finance class at the Sloan School. He is also a Charter Member with TiE and serves on the University of Michigan's Technology Transfer National Advisory Board. Mr. Stjernfeldt is the Treasurer of the New England Venture Capital Association and as a board member for the Massachusetts Networks Communications Council, he leads the Innovators Summit committee.
Nicholas P. Sullivan has written and spoken widely about technology, entrepreneurship, and international development. He is author of You Can Hear Me Now: How Microloans and Cell Phones Are Connecting the World's Poor to the Global Economy (Jossey-Bass, 2007), which tracks the mobile phone explosion in South Asia and Africa.
Sullivan is publisher of Innovations: Technology/Governance/Globalization (an MIT Press journal), a partner in the Global Horizon Fund, a fund-of-funds for frontier economies, and a member of the working group for the GSM Association's "Mobile Money for the Unbanked" initiative (Gates Foundation). He is part of the M-Banking 2009: Balancing Innovation and Regulation conference in Nairobi, Kenya in May, 2009, co-sponsored by The Fletcher School with the Central Bank of Kenya.
Previously, he was editor-in-chief of Inc.com and Home Office Computing magazine (Scholastic Inc.) He was a United Nations accredited business interlocutor to the International Financing for Development conference, a visiting fellow at the Feinstein Center at Tufts University, and a visiting scholar at MIT's Legatum Center for Development & Entrepreneurship. Sullivan is a graduate of Harvard University and The Fletcher School.
Dorothy Suput is the founder and Executive Director of The Carrot Project, a non-profit organization dedicated to creating small-farm financing solutions in collaboration with lenders, farm support organizations, and investors. Whether as the executive director of a nonprofit, a senior executive responsible for raising millions of dollars for controversial advocacy, or the energy behind The Carrot Project, Dorothy has consistently demonstrated the intelligence and humor needed to be a successful entrepreneur. Dorothy has gained the trust and commitment of sustainable agriculture leaders and researchers across the country because of her reputation forged during her professional work on the 1995 Farm Bill, her volunteer efforts on behalf of the community since that time, and the innovation and potentially ground-breaking solutions offered by The Carrot Project. Dorothy earned an M.A. in Environmental Policy from Tufts University. She serves on the boards of Red Tomato and the Organic Farming Research Foundation.
Joseph L. Ternullo, JD, MPH, is Associate Director of the Center for Connected Health at Partners HealthCare System in Boston, Massachusetts. His responsibilities include enterprise-wide relationships within Partners, corporate collaborations, national and world-wide strategic alliances, and public policy. Founder and organizing Chair of a celebrated annual symposium focused on critical issues associated with connected health, Mr. Ternullo is a founding member and Board Vice President of the Continua Health Alliance.
Joe serves on the Massachusetts General Hospital and Brigham & Women's Hospital institutional review boards. He is a member of the Board of Directors of Massachusetts Health Quality Partners and sits on the policy committee of the American Telemedicine Association and the national advisory board of the Center for e-Health Law. He is also associate director of the Northeast Telehealth Resource Center, a consortium operated through a grant from the US Office for the Advancement of Telehealth. He recently completed a term on the Chronic Care Workgroup of the American Health Information Community, the body that advises the U.S. Dept. of Health and Human Services on accelerating national development and adoption of health information technology. Joe holds degrees from Boston College, Boston University, Bentley College and Harvard University. He serves as adjunct faculty of the graduate Computer and Information Science Department at Northeastern University, where he teaches healthcare informatics law.
Richard M Toselli, MD is presently Vice President of Evidence Based Medicine for the device and diagnostic sector of J&J. He reports to Harlan Weisman, MD in the Office of Science and Technology. Dr. Toselli is neurosurgeon by training and was in academic practice before joining J&J four years ago. He has his MBA in addition to his medical degree. He has held numerous roles at J&J including a leadership role in R&D as well as in Clinical and Regulatory Affairs. His present role involves creating strategy and finding resources to improve evidence generation in the device and diagnostic businesses of J&J.
Brad Vale, PhD, DVM, Vice President, Head of Venture Investments, joined Johnson & Johnson Development Corporation (JJDC) in 1992. In July 1997, Dr. Vale moved to California to establish the Silicon Valley office. Since joining JJDC, he has invested in over 30 companies, including five that were ultimately acquired by various Johnson & Johnson subsidiaries. In 2008, Dr. Vale was appointed to the position of Vice President, Head of Venture Investments and is based in Silicon Valley, California.
Prior to joining JJDC, Dr. Vale was supporting Johnson & Johnson's medical device businesses at the Corporate Office of Science and Technology. From 1982 to 1989, he was at Ethicon, Inc., a Johnson & Johnson subsidiary, working on preclinical studies, new business development, and a coronary artery bypass graft internal venture.
Dr. Vale has extensive experience in medical device research and development, including blood-compatible polymers, lasers, microsurgery, novel tissue closure, and hyaluronic acid for adhesion prevention. He is a published author in the area of medical device development. Dr. Vale received a PhD in Biomedical Engineering from Iowa State University and a Doctor of Veterinary Medicine from Washington State University.
Frank von Mierlo is the cofounder of 1366 Technologies together with MIT Professor Ely Sachs. The goal of 1366 Technologies is to make silicon solar cells cost competitive with coal generated electricity. Prior to 1366 Technologies, Frank was the founder of Bluefin Robotics Corporation together with MIT's Dr. James Bellingham. Bluefin enjoyed double digit growth and was always profitable under Frank's leadership. Bluefin became the leading robotics company in its field and is known for its technical competence and a customer centric approach. The company maintained a strong balance sheet, a healthy cash flow and a team of highly qualified engineers. Held the team together under intense schedule and recruiting pressure. Bluefin was sold to Battelle and the shareholders made a 442% return on their investment. Previous employers include Raychem and Shell. Frank hold an MBA INSEAD, France, and engineering degrees from Stanford and MIT.
Nick Weinand directs the document and print strategy for Raytheon Integrated Defense Systems. He has experience with aspects of media production ranging from effective written communication to print design to web development. With a degree from University of Arizona in Communication, he is currently focused on targeting the behavior change required to make a sustainable GreenIT strategy truly effective in a diverse workforce of more than 13,000 employees.
A large portion of this strategy, the PrintSmart Campaign, employs efficient use of network infrastructure, software and appropriate communication techniques, which have resulted in a reduction in the number of print devices and total print volume across Raytheon Integrated Defense Systems. This means that hundreds of devices are no longer drawing electricity, producing pounds of physical waste and costing Raytheon tens of thousands of dollars monthly.
These efforts, along with other GreenIT initiatives across the enterprise, recently resulted in Raytheon's receipt of the U.S. Environmental Protection Agency's Energy Star Award for Sustained Excellence and InfoWorld's Green 15 Award.
Raytheon's Green IT strategy is laying a foundation for sustainable technology practices that promise to reduce Raytheon's carbon footprint and help employees make greener decisions both at work and at home.